Advertisement

Topics

Pfizer, IBM partner to advance immuno-oncology research

03:08 EST 2 Dec 2016 | Pharmaceutical Business Review

Pharmaceutical major Pfizer and technology giant IBM have partnered to accelerate immuno-oncology research.

Original Article: Pfizer, IBM partner to advance immuno-oncology research

NEXT ARTICLE

More From BioPortfolio on "Pfizer, IBM partner to advance immuno-oncology research"

Quick Search
Advertisement
 

Relevant Topics

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...